Category: Peptide Q&A

What are the key factors influencing the stability and shelf-life of glutathione supplements, and how do storage conditions affect potency?

What is the relationship between glutathione levels and the development of non-alcoholic fatty liver disease (NAFLD), and can supplementation reverse he

How does glutathione interact with metal ions such as mercury and lead, and what are the implications for detoxification?

Why is intravenous glutathione often preferred over oral forms despite lower bioavailability, and what are the pharmacokinetic differences?

Can glutathione supplementation enhance recovery from chemotherapy-induced mucositis, and what is the supporting clinical evidence?

Are there documented cases of glutathione-induced hypersensitivity reactions or autoimmune exacerbations, and how common are they?

What is the evidence for glutathione’s role in reducing the severity of allergic reactions and asthma symptoms?

What do randomized controlled trials say about glutathione’s impact on oxidative stress markers in patients with HIV or chronic hepatitis C?

How does glutathione deficiency contribute to the pathogenesis of amyotrophic lateral sclerosis (ALS), and can supplementation slow progression?

How does glutathione compare to alpha-lipoic acid in supporting mitochondrial health and reducing oxidative damage in aging?